gorodenkoff/iStock via Getty Images After AbbVie Inc.'s ( ABBV ) most recent earnings back in early February, I provided an update for the stock . As you can see below, I reiterated my buy rating. While I found resilient growth, solid guidance, and a quite attractive valuation, AbbVie has seen some notable declines since then. Their next earnings report isn't due until later this month, but I have...
gorodenkoff/iStock via Getty Images After AbbVie Inc.'s ( ABBV ) most recent earnings back in early February, I provided an update for the stock . As you can see below, I reiterated my buy rating. While I found resilient growth, solid guidance, and a quite attractive valuation, AbbVie has seen some notable declines since then. Their next earnings report isn't due until later this month, but I have decided to provide an update now as there have recently been some notable developments on many fronts. That includes guidance revisions and study results. Seeking Alpha In the below analysis, it is shown that the lowering of EPS guidance for both Q1 and the full year is unconcerning, as acquired IPR&D and milestone expenses are a normal part of AbbVie's business. Furthermore, despite a mix of good and bad news recently, the valuation seems too low for how strong their pipeline is right now. Therefore, I have decided to reiterate my buy rating for the stock ahead of their Q1 earnings report later this month. A Refresher For 2025 Q4 Data by YCharts Before we get into the developments after their 2025 Q4, I would like to provide a very brief refresher on where things are at for the company in terms of their financial results. For the fourth quarter, you can see above that they saw top-line growth of 10.04% YoY, and that represented the strongest increase we have seen in years. This shows that business activity has remained strong for AbbVie despite headwinds originating from the Trump Administration's policies on the pharmaceutical industry. In my previous article, I also highlighted that their key immunology segment saw overall solid results, and since their focus is primarily on this space, this was an encouraging sign. Seeking Alpha On the profitability side of things, AbbVie also showed off robust results. A key measure of core profitability is, of course, operating margin, and for Q4, they reported an adjusted figure of 38.3%. As mentioned in my February update, there we...
Developer China Vanke Co. told some bondholders that it is seeking to extend a yuan bond due this month with an offer to repay 40% of the principal upfront, according to people familiar with the matter, as it again races to avoid default. Vanke is considering offering the same terms as earlier proposals to extend three other bonds by a year, the people added, highlighting how a company at the epic...
Developer China Vanke Co. told some bondholders that it is seeking to extend a yuan bond due this month with an offer to repay 40% of the principal upfront, according to people familiar with the matter, as it again races to avoid default. Vanke is considering offering the same terms as earlier proposals to extend three other bonds by a year, the people added, highlighting how a company at the epicenter of China’s property crisis is still facing liquidity challenges. The company would need the support of holders of more than 90% of the notes for the plan to take effect, according to the prospectus. The bond, which has 2 billion yuan ($293 million) outstanding, is set to mature on April 23. Vanke’s proposal isn’t final and could change, the people said, asking not to be identified as the matter is private. Vanke, which posted a record 88.6 billion yuan loss last year, is one of China’s few major property developers to so far avoid default. But the next few months are critical as it has more than 11 billion yuan of bond maturities looming through July, with five onshore notes and two put options that could be exercised before the end of that month. The builder will send final proposals on the April bond to holders by next Tuesday and meet with them on April 17 to discuss the extension plans, according to a company filing , which didn’t provide further details. The bond last traded at about 51 yuan in late March, amid thin liquidity, according to data compiled by Bloomberg. Dates Bond Ticker Principal Amount (Yuan) Maturity Type April 23 VANKE 3.11 04/23/26 2 billion Maturity May 12 VANKE 3.1 05/12/26 2 billion Maturity May 20 VANKE 3.7 05/20/28 566 million Put Option June 15 VANKE 3.07 06/15/26 2 billion Maturity July 7 VANKE 3.07 07/07/26 2 billion Maturity July 24 VANKE 3.1 07/24/26 2 billion Maturity July 26 VANKE 3.49 07/26/28 700 million Put Option Vanke didn’t immediately respond to a request for comment. Delaying payment on the April note would buy Vanke some ti...
Evgeny Gromov/iStock via Getty Images By Elior Manier NZD/USD has been thrashed since the start of the US-Iran war, amid heavy concerns about energy supply in the Land of the Kiwi. At the beginning of 2026, the New Zealand dollar was on a powerful run. Traders priced higher odds for rate hikes, while most other central banks were priced for pauses and cuts. Since then, pricing has dramatically shi...
Evgeny Gromov/iStock via Getty Images By Elior Manier NZD/USD has been thrashed since the start of the US-Iran war, amid heavy concerns about energy supply in the Land of the Kiwi. At the beginning of 2026, the New Zealand dollar was on a powerful run. Traders priced higher odds for rate hikes, while most other central banks were priced for pauses and cuts. Since then, pricing has dramatically shifted. Numerous policymakers now hint at incoming rate hikes to diminish the inflationary impact of 60% rises in oil prices. Having lost some relative strength, the new Governor Anna Breman failed to forecast a significant hawkish turn that had been anticipated by market participants earlier in the year. You can access her recent speech right here . Having missed its Q4 GDP data, released in mid-March, traders quickly began pricing out any signs of heating in the NZ economy. Combine these factors with a gigantic rise in the petrodollar since March, and traders got exactly what they needed to not only take profits on previous bullish views but also reverse them into a bearish trend – the major pair is down 4.75% since. The upcoming meeting is strongly priced for a pause (about 90% odds). However, traders have priced in 60 basis points of hikes for the rest of the year. Given the turn in fundamentals and upcoming event, the drops in NZD/USD might just be over. Traders will focus on New Zealand macro data and especially the Royal Bank's inflation outlook for the next meeting (May 27, 2026). Combine high odds of more hawkish communications with daily bullish divergences (see below), and the NZD/USD could be poised for a decent upside reversal – the rest will be to see if it leads to a proper uptrend. To prepare for the upcoming key RBNZ meeting this evening, it is appropriate to conduct a multi-timeframe analysis of NZD/USD and assess potential scenarios. NZD/USD Multi-Timeframe Technical Analysis Daily Chart NZD/USD Daily Chart – Source: TradingView. April 7, 2026 The Kiwi doll...
According to The Motley Fool's 2026 Best Places to Retire report, West Virginia has the cheapest housing costs. Unfortunately, it is also one of the most expensive states for living costs. This highlights the need to examine more than just one variable when you are considering where to live in retirement. If you are looking to keep your costs down in 2026, these are the five states you'll want to ...
According to The Motley Fool's 2026 Best Places to Retire report, West Virginia has the cheapest housing costs. Unfortunately, it is also one of the most expensive states for living costs. This highlights the need to examine more than just one variable when you are considering where to live in retirement. If you are looking to keep your costs down in 2026, these are the five states you'll want to look at first. The Motley Fool's 2026 Best Places to Retire report places Arkansas at the head of the pack for living costs. And it sits at number five in terms of housing costs. That's a good balance for those who are looking to retire on the cheap. Image source: Getty Images. Continue reading
IREN (NasdaqGS:IREN) is back in focus after its pivot toward AI cloud infrastructure, anchored by a five year, multibillion dollar data center capacity deal with Microsoft, raised fresh questions about execution and funding. See our latest analysis for IREN. At a latest share price of $35.74, IREN has a 1 day share price return of 1.74% and a 7 day share price return of 4.26%. However, the 90 day ...
IREN (NasdaqGS:IREN) is back in focus after its pivot toward AI cloud infrastructure, anchored by a five year, multibillion dollar data center capacity deal with Microsoft, raised fresh questions about execution and funding. See our latest analysis for IREN. At a latest share price of $35.74, IREN has a 1 day share price return of 1.74% and a 7 day share price return of 4.26%. However, the 90 day share price return of 18.07% and year to date share price return of 16.30% point to fading short...